Charles Schwab’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $667K | Sell |
529,449
-197,773
| -27% | -$249K | ﹤0.01% | 3032 |
|
|
2025
Q1 | $664K | Sell |
727,222
-18,504
| -2% | -$16.9K | ﹤0.01% | 2985 |
|
|
2024
Q4 | $1.19M | Buy |
745,726
+6,196
| +0.8% | +$9.85K | ﹤0.01% | 2850 |
|
|
2024
Q3 | $1.45M | Buy |
739,530
+118,325
| +19% | +$232K | ﹤0.01% | 2798 |
|
|
2024
Q2 | $1.02M | Sell |
621,205
-203,452
| -25% | -$334K | ﹤0.01% | 2928 |
|
|
2024
Q1 | $4.24M | Buy |
824,657
+16,898
| +2% | +$86.9K | ﹤0.01% | 2339 |
|
|
2023
Q4 | $4.63M | Buy |
807,759
+215,910
| +36% | +$1.24M | ﹤0.01% | 2343 |
|
|
2023
Q3 | $2.83M | Buy |
591,849
+179,224
| +43% | +$857K | ﹤0.01% | 2494 |
|
|
2023
Q2 | $1.75M | Buy |
412,625
+2,176
| +0.5% | +$9.25K | ﹤0.01% | 2589 |
|
|
2023
Q1 | $2.18M | Buy |
410,449
+5,547
| +1% | +$29.5K | ﹤0.01% | 2503 |
|
|
2022
Q4 | $2.54M | Buy |
404,902
+6,191
| +2% | +$38.9K | ﹤0.01% | 2491 |
|
|
2022
Q3 | $4.21M | Buy |
398,711
+191,492
| +92% | +$2.02M | ﹤0.01% | 2301 |
|
|
2022
Q2 | $1.13M | Sell |
207,219
-7,326
| -3% | -$39.8K | ﹤0.01% | 2743 |
|
|
2022
Q1 | $1.97M | Buy |
214,545
+72,029
| +51% | +$661K | ﹤0.01% | 2651 |
|
|
2021
Q4 | $2.15M | Buy |
142,516
+9,239
| +7% | +$139K | ﹤0.01% | 2686 |
|
|
2021
Q3 | $3.18M | Buy |
+133,277
| New | +$3.18M | ﹤0.01% | 2584 |
|